NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,077 filers reported holding NOVARTIS A G in Q3 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $775,853 | -0.9% | 7,684 | 0.0% | 0.09% | -12.7% |
| Q3 2023 | $782,692 | -1.6% | 7,684 | -2.5% | 0.10% | 0.0% |
| Q2 2023 | $795,574 | +9.7% | 7,884 | 0.0% | 0.10% | +3.0% |
| Q1 2023 | $725,328 | +1.4% | 7,884 | 0.0% | 0.10% | -3.9% |
| Q4 2022 | $715,236 | +15.0% | 7,884 | -3.7% | 0.10% | +6.2% |
| Q3 2022 | $622,066 | -14.3% | 8,184 | -4.7% | 0.10% | -7.6% |
| Q2 2022 | $725,606 | -3.7% | 8,584 | 0.0% | 0.10% | +10.5% |
| Q1 2022 | $753,246 | +0.3% | 8,584 | 0.0% | 0.10% | +2.2% |
| Q4 2021 | $750,842 | +11.3% | 8,584 | +4.0% | 0.09% | -1.1% |
| Q3 2021 | $674,685 | -16.1% | 8,250 | -6.4% | 0.09% | -15.3% |
| Q2 2021 | $804,281 | +3.2% | 8,815 | -3.3% | 0.11% | -6.7% |
| Q1 2021 | $779,150 | -9.5% | 9,115 | 0.0% | 0.12% | -23.2% |
| Q4 2020 | $860,729 | +6.3% | 9,115 | -2.1% | 0.16% | -5.5% |
| Q3 2020 | $810,032 | -1.9% | 9,315 | -1.5% | 0.16% | -11.4% |
| Q2 2020 | $825,800 | +4.0% | 9,455 | -1.8% | 0.18% | -9.8% |
| Q1 2020 | $793,994 | -12.7% | 9,630 | +0.3% | 0.20% | +5.7% |
| Q4 2019 | $909,119 | +5.7% | 9,601 | -3.0% | 0.19% | -2.0% |
| Q3 2019 | $860,397 | -4.8% | 9,901 | 0.0% | 0.20% | -7.9% |
| Q2 2019 | $904,060 | -18.2% | 9,901 | -13.9% | 0.22% | -22.1% |
| Q1 2019 | $1,105,225 | +11.6% | 11,496 | -0.4% | 0.28% | -2.1% |
| Q4 2018 | $990,762 | -13.7% | 11,546 | -13.4% | 0.28% | +7.2% |
| Q3 2018 | $1,148,513 | +14.1% | 13,330 | 0.0% | 0.26% | +6.0% |
| Q2 2018 | $1,006,948 | -7.3% | 13,330 | -0.7% | 0.25% | -12.7% |
| Q1 2018 | $1,085,816 | -7.8% | 13,430 | -4.3% | 0.28% | -9.0% |
| Q4 2017 | $1,177,959 | -3.2% | 14,030 | -1.1% | 0.31% | -12.6% |
| Q3 2017 | $1,217,353 | +2.9% | 14,180 | 0.0% | 0.36% | -9.2% |
| Q2 2017 | $1,183,605 | +58.1% | 14,180 | +40.7% | 0.39% | +52.9% |
| Q1 2017 | $748,642 | +13.4% | 10,080 | +11.2% | 0.26% | +4.0% |
| Q4 2016 | $660,003 | -11.7% | 9,061 | -4.2% | 0.25% | -14.8% |
| Q3 2016 | $747,041 | -4.3% | 9,461 | 0.0% | 0.29% | -5.8% |
| Q2 2016 | $780,627 | +38.9% | 9,461 | +21.9% | 0.31% | +33.9% |
| Q1 2016 | $562,207 | – | 7,761 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |